Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
43,200
-750 (-1.71%)
Jan 19, 2026, 3:30 PM KST
58.82%
Market Cap1.65T
Revenue (ttm)23.23B
Net Income (ttm)-13.14B
Shares Out38.26M
EPS (ttm)-343.51
PE Ration/a
Forward PE240.00
Dividendn/a
Ex-Dividend Daten/a
Volume300,191
Average Volume521,857
Open43,800
Previous Close43,950
Day's Range43,050 - 44,800
52-Week Range24,500 - 66,000
Beta1.31
RSI37.57
Earnings DateMar 19, 2026

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.